Clinical Trials Directory

Trials / Completed

CompletedNCT06667570

Efficacy of the SALFOAM 3% Method Compared to the Conventional Polidocanol Foam Method (Tessari Method) for Treating Lower Limb Varicose Veins

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Lidiane Rocha · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial aims to assess the efficacy and safety of the SALFOAM 3% method, which involves saline wash, polidocanol 3% foam injection, and extrinsic compression using Lidstop®, in comparison with the conventional Tessari method for the treatment of lower limb varicose veins. The primary objective is to determine whether the SALFOAM 3% method results in better or equivalent vein occlusion rates and fewer adverse effects, such as hyperpigmentation, compared to the standard treatment.

Detailed description

Chronic venous disease (CVD) is prevalent in approximately 38% of the adult population in Brazil, posing significant public health challenges due to its potential complications, including ulcerations and reduced quality of life. The SALFOAM 3% method is a novel approach that combines saline wash prior to polidocanol 3% foam sclerotherapy and extrinsic compression with Lidstop®, aiming to improve outcomes by reducing adverse effects such as hyperpigmentation and enhancing patient quality of life. This randomized controlled trial will compare the efficacy, safety, and quality of life outcomes of patients treated with the SALFOAM 3% method versus those treated with the conventional Tessari method for lower limb varicose veins.

Conditions

Interventions

TypeNameDescription
PROCEDURESALFOAM 3%* Drug: Polidocanol 3% * Device: Lidstop®
PROCEDUREControl Group* Drug: Polidocanol 3% * Device: Standard compression with dental roll and elastic stockings

Timeline

Start date
2024-10-25
Primary completion
2025-02-14
Completion
2025-02-14
First posted
2024-10-31
Last updated
2025-11-25

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT06667570. Inclusion in this directory is not an endorsement.